However, lung adenocarcinoma patients with high expression of TP63 and Ago2 presented with better overall survival at early time points, but those with high levels of p63 had lower overall survival times at later time points, suggesting that overall survival might serve as a prognostic indicator of patients with these cancers (Fig. 3G, H). This evidence concerns the gene AGO2 and cancer.